Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Recent News

01.03 2019
Translate Bio Appoints Robert Meyer, MD, to its Board of Directors
01.03 2019
Translate Bio Advances Programs in Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency
12.04 2018
Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)
11.08 2018
Translate Bio Announces Third Quarter 2018 Financial Results and Reviews Recent Highlights

View All

@TranslateBio